Rainer Spanagel

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Rainer Spanagel (born 24 June 1961) is a German scientist. He is a professor of psychopharmacology at the Central Institute of Mental Health (Mannheim) of Heidelberg University, where he is director of the Institute of Psychopharmacology. His main research interest is drug abuse, especially alcohol dependence.

Works

His work has been published in multiple publications across prestigious scientific journals. Based on preclinical findings, he pursues three objectives along with other faculty at the Central Institute of Mental Health: 1) The development of new behavioral therapies, pharmacological interventions, and neuromodulatory approaches in addicted patients.

2) To clarify the neurobiological long-term consequences of drug abuse and binge-drinking in adolescents 3) The identification of risk factors for addictive disorders and development of preventive strategies. General field of study: Psychopharmacology, Addiction Research, Alcohol Abuse

Early life

Rainer Spanagel (born 24 June 1961) is a German scientist. He is a professor of psychopharmacology at the Central Institute of Mental Health (Mannheim) of Heidelberg University, where he is director of the Institute of Psychopharmacology. His main research interest is drug abuse, especially alcohol dependence.

His work has been published in multiple publications across prestigious scientific journals. Based on preclinical findings, he pursues three objectives along with other faculty at the Central Institute of Mental Health: 1) The development of new behavioral therapies, pharmacological interventions, and neuromodulatory approaches in addicted patients.

2) To clarify the neurobiological long-term consequences of drug abuse and binge-drinking in adolescents 3) The identification of risk factors for addictive disorders and development of preventive strategies. General field of study: Psychopharmacology, Addiction Research, Alcohol Abuse Spanagel completed his undergraduate studies in Biology at the University of Tübingen and LMU Munich (1983-1989) and his Ph.D. in Neuropharmacology from the Max Planck Institute of Neuropharmacology (Martinsried, Germany), working under Prof. Albert Herz (1991).

In 1989, he obtained his Diploma in Neuropharmacology from the Max Planck Institute of Neuropharmacology (Martinsried, Germany). He followed up with his post-doctoral training with Prof. Wolfgang Forth in the Habilitation, Pharmacology & Toxicology Department at LMU Munich (Munich, Germany) in 1996.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1366630524 under CC BY-SA 4.0; modifications have been made.

References

1 claim could not be tied to a specific sentence and is listed in the table below instead.